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This structural and biophysical study exploited a method of perdeuterating hen
egg-white lysozyme based on the expression of insoluble protein in Escherichia
coli followed by in-column chemical refolding. This allowed detailed
comparisons with perdeuterated lysozyme produced in the yeast Pichia pastoris,
as well as with unlabelled lysozyme. Both perdeuterated variants exhibit
reduced thermal stability and enzymatic activity in comparison with hydro-
genated lysozyme. The thermal stability of refolded perdeuterated lysozyme is
4.9C lower than that of the perdeuterated variant expressed and secreted in
yeast and 6.8C lower than that of the hydrogenated Gallus gallus protein.
However, both perdeuterated variants exhibit a comparable activity. Atomic
resolution X-ray crystallographic analyses show that the differences in thermal
stability and enzymatic function are correlated with refolding and deuteration
effects. The hydrogen/deuterium isotope effect causes a decrease in the stability
and activity of the perdeuterated analogues; this is believed to occur through a
combination of changes to hydrophobicity and protein dynamics. The lower
level of thermal stability of the refolded perdeuterated lysozyme is caused by the
unrestrained Asn103 peptide-plane flip during the unfolded state, leading to a
significant increase in disorder of the Lys97–Gly104 region following subsequent
refolding. An ancillary outcome of this study has been the development of an
efficient and financially viable protocol that allows stable and active
perdeuterated lysozyme to be more easily available for scientific applications.
1. Introduction
Biomolecular deuteration is widely used in structural biology,
where it plays a crucial role in techniques such as neutron
macromolecular crystallography (NMX), small-angle neutron
scattering (SANS), neutron reflectometry (NR), neutron
spectroscopy and nuclear magnetic resonance (NMR)
(Haertlein et al., 2016; Varga et al., 2007). For neutron studies,
the fact that deuterium (D), an isotope of hydrogen (H),
possesses a positive coherent neutron scattering length and a
small incoherent neutron scattering cross section, and also an
integer nuclear spin, is of central importance. In NMX,
perdeuteration may be used to eliminate the incoherent
scattering arising from the two spin states of the H atom
(incoherent scattering cross section of 80.27 barns; Sears,
1992); this allows the use of samples that are approximately
one order of magnitude smaller by volume (Hazemann et al.,
2005) and may result in improved resolution (Blakeley, 2009).
Perdeuteration enhances the visibility of the coherent signal
(Bragg reflections), fully exploiting the higher coherent scat-
tering length of deuterium (6.67 fm) in comparison with that
of hydrogen (3.74 fm). Furthermore, perdeuteration helps to
avoid cancellation effects (arising from the negative scattering
length of hydrogen) that may occur for neutron Fourier maps
based on data with intermediate resolution (for example
d > 1.6 Å). In SANS, the use of deuterated samples allows
contrast-matching techniques (Dunne et al., 2017; Laux et al.,
2008; Haertlein et al., 2016) to provide unique information on
protein–protein (Vijayakrishnan et al., 2010), protein–nucleic
acid (Cuypers, Trubitsyna et al., 2013) or protein–lipid
(Breyton et al., 2013) interactions. Sophisticated technologies
have also been developed to allow the production of stealth-
deuterated nanodiscs (Maric et al., 2014, 2015) for the study of
membrane proteins (Josts et al., 2018; Nitsche et al., 2018;
Kehlenbeck et al., 2019). In the case of NR, a wide range of
research now routinely exploits the contrast enabled through
the use of selective deuteration (Grage et al., 2011; Moulin et
al., 2018; Waldie et al., 2018, 2019, 2020). Deuterium labelling
and reverse labelling have also been used for neutron scat-
tering studies of the dynamics of biological macromolecules
(Foglia et al., 2016), in particular when coupled with
hydration water dynamics (Wood et al., 2013). In the case of
solution-state NMR, deuterium labelling is essential for
multidimensional heteronuclear NMR studies of proteins,
especially high-molecular-weight proteins and macro-
molecular complexes. Partial deuteration simplifies the NMR
spectra from the remaining 1H nuclei and also contributes to
spectra with a higher signal-to-noise ratio owing to the effects
on the relaxation of bonded or adjacent 1H, 13C and 15N atoms
(Sattler & Fesik, 1996). While major developments in in vivo
deuteration technologies have occurred in the last 15 years,
the expression of deuterated protein is often complex and
expensive and may be associated with low yields. The way in
which it is carried out depends on the downstream application
and on the labelling regime needed to answer the scientific
questions posed (Haertlein et al., 2016). In the case of neutron
crystallographic applications, the goal is invariably to
perdeuterate the sample so that the incoherent scattering from
hydrogen is removed from the recorded data to the maximum
possible extent.
Hen egg-white lysozyme (HEWL) was the first enzyme
structure to be solved by X-ray crystallography (Blake et al.,
1965), and has subsequently become a widely used model in
structural biology in a variety of contexts including protein-
folding studies (Miranker et al., 1991, 1993; Radford et al.,
1992; Wildegger & Kiefhaber, 1997) and crystallization
(Durbin & Feher, 1986; McPherson & DeLucas, 2015;
Darmanin et al., 2016). It is a small (129 residues, 14.3 kDa)
and stable protein that in its hydrogenated form can be
acquired at low cost and crystallized in numerous space groups
under well known conditions. HEWL is a hydrolase from
Gallus gallus that cleaves the 1,4--linkages between N-acetyl-
muramic acid and N-acetyl-d-glucosamine residues in
peptidoglycan. The recombinant production of HEWL in
Escherichia coli is challenged by the reductive environment of
the bacterial cytosol, which prevents the correct formation of
its four disulfide bridges, resulting in the formation of inclu-
sion bodies. The use of the yeast Pichia pastoris has been
investigated as an expression system for the production of
recombinant HEWL (Liu et al., 2003; Li et al., 2012; Mine et al.,
1999; Campbell et al., 2018). While this approach results in the
production of high-quality protein, the low yield is problem-
atic for neutron crystallographic and spectroscopic applica-
tions. For this reason, we developed an approach whereby
large quantities of insoluble protein were produced as inclu-
sion bodies in E. coli, followed by an optimized refolding
process, significantly improving the yield.
Using this strategy, large amounts of correctly folded
perdeuterated HEWL (D-HEWL) can be obtained at a
financially viable level. Of particular interest is the fact
that the refolded perdeuterated lysozyme from E. coli
(D-HEWLEC) provides important insights into the structural
and biophysical properties of HEWL when compared with
those of the perdeuterated analogue produced in P. pastoris
(D-HEWLPP) and those of the commercially available non-
recombinant hydrogenated protein (H-HEWL). These
variants are identical in primary structure, with the exception
of an additional glycine at the N-terminus of D-HEWLEC.
Atomic resolution X-ray structures have been determined
for all three variants using triclinic crystals obtained in closely
comparable conditions. The effect of deuteration on reduced
thermal stability and activity is noted. The structural analyses
highlight subtle but important differences that are related to
the decrease in the thermal stability of D-HEWLEC; these
differences are of significance for protein folding (Biter et al.,
2016), enzymatic activity (Lea & Simeonov, 2012), crystal-
lization (Geders et al., 2012; Reinhard et al., 2013) and
protein–ligand interactions (Bai et al., 2019; Forneris et al.,
2009; Holdgate et al., 2010; Ramos et al., 2019). The improved
yield (by a factor of more than three compared with that found
using P. pastoris) paves the way for a wide range of studies
that can exploit H/D isotopic substitution in this protein.
2. Methods
2.1. Expression of D-HEWLEC
Recombinant D-HEWL was overexpressed in E. coli BL21
(DE3) cells grown in a Labfors 2.3 l computer-controlled
fermenter (Infors, France) using a high cell-density culture
(HCDC) strategy. Transformation of chemically competent
cells with the vector pET-28a(+) (GenScript) containing
codon-optimized cDNA for HEWL expression (Supplemen-
tary Fig. S1) was performed by heat shock. Using a lysogeny
broth (LB) solid medium supplemented with 40 mg ml1
kanamycin (catalogue No. 60615; Sigma–Aldrich), trans-
formed cells were selected. The cells containing the vector
were then adapted to hydrogenated Enfors minimal medium
containing hydrogenated glycerol and kanamycin. The cells
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were further adapted to fully deuterated Enfors medium
supplemented with d8-glycerol (catalogue no. DLM-558-PK;
Eurisotop) and antibiotic. 100 ml precultures were prepared
to inoculate 1.4 l minimal medium in the fermenter. During
batch and fed-batch phases, the pD (pD = pHmeasured + 0.4;
Glasoe & Long, 1960) was maintained at 6.4 by adding NaOD.
The gas-flow rate of sterile-filtered air was 0.5 l min1. Stirring
was adjusted to ensure a dissolved oxygen level of 30%. The
initial glycerol supply was consumed during the batch phase.
The cells were then fed continuously with fresh feeding solu-
tion containing 12% d8-glycerol in an exponential manner
(fed-batch phase). When the cell density reached an OD of 10,
recombinant protein expression was induced by adding IPTG
to a final concentration of 1 mM. The cells were harvested
after 24 h of induction. The final volume of cell culture
extracted from the fermenter was approximately 1.8 l.
2.2. Inclusion-body separation of D-HEWLEC
The inclusion bodies were purified in a centrifugation-based
approach, with several washing steps to remove nucleic acids,
lipids and other contaminants. After pelleting the E. coli cells,
lysis was promoted by sonication with a Vibra-Cell ultrasonic
liquid processor (VCX-750-220, Sonics & Materials),
performing three cycles of 30 s at amplitude 0.8 in a buffer
consisting of 0.1 M Tris–HCl pH 8.45, 150 mM NaCl, 25 mM
EDTA, 25 mM DTT, 0.5% Triton X-100. The suspension was
centrifuged at 10 080g for 1 h at 4C to separate the soluble
and insoluble fractions. The supernatant was discarded and
the pellet was solubilized in 0.1 M Tris–HCl pH 8.45, 150 mM
NaCl, 25 mM EDTA, 25 mM DTT, 1 M guanidine–HCl, 1%
Triton X-100 using a homogenizer (D1000, Benchmark). The
suspension was sonicated three times for 10 s at amplitude 0.4
and was then centrifuged at 22 680g for 30 min at 4C. This
washing step was performed six times, with Triton X-100
excluded from the buffer in the last two cycles.
2.3. Purification of D-HEWLEC
The inclusion bodies were solubilized in 0.1 M Tris–HCl pH
8.45, 150 mM NaCl, 25 mM EDTA, 25 mM DTT, 6 M guani-
dine–HCl using a homogenizer. The suspension was sonicated
three times for 10 s at amplitude 0.4 and then centrifuged at
22 680g for 1 h at 4C. The soluble fraction was collected and
filtered through 0.4 mm filters. Purification of unfolded protein
was performed by gel filtration on a HiLoad 16/600 Superdex
200 pg column (GE Healthcare) equilibrated in the same
buffer. Protein fractions of 5 ml were diluted to avoid
saturation of the UV detector of the HPLC and were injected
into the column, running an isocratic flow at 1.0 ml min1.
Pure protein eluted at 0.6–0.7 column volumes (CV). The
fractions of pure protein collected were frozen at 80C until
the refolding procedure.
2.4. Refolding of D-HEWLEC
Denatured protein was refolded at room temperature in a
size-exclusion chromatography (SEC) setup using a HiLoad
16/600 Superdex 200 pg column equilibrated with 0.1 M Tris–
HCl pH 8.45, 2 M urea, 1 mM EDTA, 3 mM reduced gluta-
thione, 0.3 mM oxidized glutathione as described by Batas &
Chaudhuri (1996). 5 ml injections of pure unfolded HEWL at
concentrations of 1–2 mg ml1 were performed in each run;
the isocratic flow was set to 0.1 ml min1, resulting in mono-
meric HEWL fractions being collected at 0.9 CV.
The protein buffer was exchanged to 50 mM sodium acetate
pD 4.5 in D2O by desalting using two coupled HiTrap 5 ml
desalting columns (GE Healthcare). Injections of 2.5 ml of
protein at 0.6 mg ml1 were performed. The protein was
subsequently concentrated to 20 mg ml1 for crystallization
experiments.
2.5. Expression and purification of D-HEWLPP
The expression of D-HEWLPP was achieved as described by
Campbell et al. (2018). Since the protein was secreted into the
extracellular medium, the supernatant was recovered upon
cell pelleting. The supernatant was diluted by the addition of
50 mM Tris–HCl pH 7.8 buffer to achieve a solution conduc-
tivity of below 10 mS cm1. Pure protein was obtained by ion-
exchange chromatography (IEC) using an SP-Sepharose
column (GE Healthcare) and elution with a 30 ml NaCl
gradient from 0 to 1 M in 50 mM Tris–HCl pH 7.8 buffer.
Following the same approach as the final buffer exchange of
D-HEWLEC, the D-HEWLPP buffer was exchanged to 50 mM
sodium acetate pD 4.5 in D2O by desalting. The protein was
concentrated to 30 mg ml1 for crystallization experiments.
2.6. Mass spectrometry (MS)
MS under denaturing conditions was utilized to assess the
mass of the intact deuterated proteins and their degree of
labelling. Specifically, liquid-chromatography/electrospray
ionization mass spectrometry (LC/ESI-MS) on a 6210 TOF
mass spectrometer coupled to an HPLC system (1100 series,
Agilent Technologies) was performed. Data acquisition was
carried out in positive-ion mode, and mass spectra were
recorded in the 300–3200 m/z range. The following experi-
mental settings were utilized: the ESI source temperature was
set to 300C, N2 was used as a drying gas (with a flow rate of
7 l min1) and as a nebulizer gas (using a pressure of 69 kPa)
and the capillary needle voltage was 4 kV. Voltages in the first
part of the instrument were set as follows: the voltage of the
fragmentor was 250 V and that of the skimmer was 60 V. The
acquisition rate was one spectrum per second. Instrument
pressure values were typically 2.33 Torr (rough vacuum) and
4.6  107 Torr (TOF vacuum). The mass spectrometer was
calibrated with tuning mix (ESI-L, Agilent Technologies). The
HPLC mobile phases were prepared with HPLC-grade
solvents. The mobile phase A composition was 95% H2O, 5%
acetonitrile (ACN), 0.03% trifluoroacetic acid (TFA). The
mobile phase B composition was 95% ACN, 5% H2O, 0.03%
TFA.
As partial D-to-H back-exchange would be possible during
the experiment, both samples were dialyzed against 50 mM
sodium acetate pH 4.5 buffer in H2O prior to the MS
experiment to ensure full back-exchange and thus allow the
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evaluation of the number of D atoms in all non-exchangeable
positions.
Just before the analysis, the samples were diluted in 0.03%
TFA to obtain a concentration of 5 mM and a volume of 20 ml.
The samples were loaded into glass vials, which were placed on
a sample loader refrigerated at 10C. 4 ml of each sample (i.e.
20 pmol of protein) was injected into the HPLC system
directly connected to the mass spectrometer. The injected
sample was first trapped and desalted on an RP-C8 cartridge
for 3 min at a flow rate of 50 ml min1 using 100% mobile
phase A. Afterwards, the proteins were separated on an RP-
C8 column using a linear gradient from 5 to 95% mobile phase
B for 15 min and subjected to ESI prior to the TOF detection
of their m/z signals. The software MassHunter BioConfirm
(version B.07.00; Agilent Technologies) was used to calculate
masses from m/z values obtained during the MS experiments.
2.7. Differential scanning fluorimetry (DSF)
DSF measurements were performed using a Prometheus
instrument (NanoTemper). The setup included a temperature
ramp from 20 to 95C with increments of 1.0C min1,
following unfolding by the intrinsic fluorescent signal from the
tryptophan residues (six tryptophans in HEWL). Lyophilized
H-HEWL powder was dissolved in 50 mM sodium acetate pD
4.5 in D2O to match the conditions of D-HEWLEC and
D-HEWLPP. The experiment was repeated in the hydro-
genated buffer of the activity assay, where the samples were
diluted in 0.1 M sodium phosphate pH 7.5, 0.1 M NaCl, 2 mM
NaN3 in H2O in a ratio of at least 1:50. The results presented
correspond to samples at concentrations of 0.3 mg ml1 with a
40% excitation power and were obtained for at least two
HEWL preparations as duplicate or triplicate measurements
for every condition.
2.8. HEWL activity assays
The activity assays were performed based on the work of
Shugar (1952). The activity is followed by the absorbance at
450 nm at 25C, with measurements every minute for 20 min.
Nunc 96-well flat-bottom plates (Thermo Fisher Scientific)
were used with each sample in triplicate, including negative
controls without protein. The 100 ml samples used for these
experiments comprised 50 ml protein sample at 0.2 mg ml1
and 50 ml Micrococcus lysodeikticus cell suspension in H2O
with 0.1 M sodium phosphate pH 7.5, 0.1 M NaCl, 2 mM
NaN3. After averaging triplicates of each experiment, the
activity curves were plotted against time, and the linear phase
(R2 > 0.91) corresponding to the first 8 min of reaction was
considered to retrieve the initial velocities. Standard devia-
tions were derived from three separate experiments and a
t-test was performed for each pair of results to assess the
significance of the homoscedastic hypothesis, meaning the
probability of the pairs of measured values being equal.
2.9. Protein crystallization
H-HEWL (catalogue No. L6876; Sigma–Aldrich) was
crystallized in the triclinic form in batch-like conditions using
a precipitation step as described by Vidal et al. (1999). 5 ml
drops were prepared consisting of 2.5 ml H-HEWL at
20 mg ml1 dissolved in deionized water and 2.5 ml 0.4 M
NaNO3, 50 mM sodium acetate pH 4.5. Under these condi-
tions, monoclinic crystals readily formed at room temperature.
To obtain the triclinic crystal form, the crystallization plate
was stored at 4C overnight and then subsequently kept at
18C. During the cold storage, crystals of both the triclinic and
monoclinic forms nucleate. When the temperature is raised,
the less stable monoclinic form dissolves, leaving almost
exclusively nuclei of the triclinic form (Legrand et al., 2002).
Triclinic crystals appeared after three days.
Triclinic crystals of D-HEWL were obtained by initial
microseeding using triclinic H-HEWL seeds from a crystal in
100% D2O buffer. The seed solution was made by crushing the
crystal in 0.3 M NaNO3, 50 mM sodium acetate pD 4.5.
Subsequently, the solution was transferred to an Eppendorf
tube containing a zirconium silicate ceramic seed bead
(Hampton Research) and vortexed to produce microseeds.
Seed stocks of 1:100 and 1:1000 dilutions were used in the
crystallization experiments. Sitting drops of 5.5 ml were
prepared by microbatch under oil and stored at 18C. The
drops consisted of 2.5 ml D-HEWLEC at 20 mg ml
1 or
D-HEWLPP at 30 mg ml
1, 2.5 ml 0.3 M NaNO3, 50 mM
sodium acetate pD 4.5 and 0.5 ml of the H-HEWL seed solu-
tion. Triclinic crystals of D-HEWL of up to 0.1 mm3 were
obtained within one week.
2.10. X-ray data collection, processing and model refinement
Synchrotron X-ray diffraction data were collected at 100 K
from crystals of H-HEWL, D-HEWLEC and D-HEWLPP. The
data collections were performed on beamline I03 at Diamond
Light Source (DLS), UK and on BioMAX at MAX IV,
Sweden (Table 1). Crystals of approximately 0.1 mm3 were
cooled in cryoprotectant solutions of 25–35%(v/v) glycerol or
d8-glycerol with 0.3 M NaNO3 and 50 mM sodium acetate
pH/pD 4.5 in H2O for H-HEWL or D2O for both D-HEWL
forms. Due to the low triclinic crystal symmetry, the data sets
were measured in two different  orientations to improve the
completeness of the data. The data were reduced, merged and
scaled using XDS (Kabsch, 2010). Initial phases were esti-
mated by molecular replacement in Phenix (Liebschner et al.,
2019), using the structure deposited in the Protein Data Bank
(PDB; Berman et al., 2000) as entry 4yeo (Shabalin et al.,
2015), stripped of ligands and water molecules, as a starting
model. Model refinement was performed using Phenix
(Liebschner et al., 2019), with the same set of reflections
flagged for the Rfree calculation. Model building was achieved
using Coot (Emsley et al., 2010). The D-HEWLEC model from
a late stage of refinement was used for the initial refinement of
D-HEWLPP and H-HEWL to maintain the labelling of residue
disorder as well as of water molecules and ions. H/D atoms
were added to the models as riding atoms in ideal positions.
The occupancy of water molecules and ions was refined for
atoms with B factors above 20 Å2 and was otherwise fixed to 1.
Water molecules which displayed a density lower than 1.5  in
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the 2Fo  Fc electron-density map were removed from the
models.
2.11. X-ray structure analysis and comparison
Structural alignment of the entire protein chains was
achieved with the CEALIGN plugin (Shindyalov & Bourne,
1998) using the C atoms from 128 residues, while alignment of
the Lys97–Gly104 region (using all atoms) was performed with
the SUPER function of PyMOL (version 2.0; Schrödinger).
EDSTATS (Tickle, 2012) from the CCP4 suite (Winn et al.,
2011) was employed to evaluate the quality of the models
according to the data, allowing the identification of residues
that may not have been reliably modelled for further analysis.
The combination of cutoffs considered was 90% for the RSCC,
1 for the sample RSZO and 3 and +3 for RSZO and
RSZO+, respectively. Hydrogen-bond analysis was performed
using HBPLUS (McDonald & Thornton, 1994). Results that
included intra-residue interactions and residues that were not
reliably modelled according to the metrics from EDSTATS
(Tickle, 2012) were not considered for the comparison
between models, with the exception of Thr89 from D-
HEWLPP, which participates in an extensive hydrogen-bond
network involving His15, Asp87 and Asn93. The graphical
representations presented here were made in PyMOL.
3. Results
3.1. Increased yield by refolding from inclusion bodies
Inclusion bodies from D-HEWLEC expression were sepa-
rated from insoluble contaminants, as shown by SDS–PAGE
of the supernatants from the washing steps (Supplementary
Fig. S2). The untagged D-HEWLEC was further purified by gel
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Table 1
X-ray diffraction data-collection and model-refinement statistics for H-HEWL, D-HEWLEC and D-HEWLPP.
Values in parentheses are for the outer resolution shell.
H-HEWL D-HEWLEC D-HEWLPP
Cryoprotectant 25%(v/v) glycerol 35%(v/v) d8-glycerol 30%(v/v) d8-glycerol
Strategy 2  orientations, 180 scans 2  orientations, 180 scans 2  orientations, 360 scans
Beamline and source I03, DLS I03, DLS BioMAX, MAX IV
Detector EIGER2 XE 16M EIGER2 XE 16M EIGER hybrid-pixel 16M
Wavelength (Å) 0.7293 0.7293 0.7999
Resolution range (Å) 31.99–1.00 (1.036–1.000) 32.01–0.98 (1.015–0.980) 32.01–1.00 (1.036–1.000)
Space group P1 P1 P1
a, b, c (Å) 26.76, 31.07, 33.77 26.67, 30.97, 33.74 26.67, 30.97, 33.74
, ,  () 89.211, 72.459, 67.863 89.439, 72.818, 67.503 89.439, 72.818, 67.503
Total reflections 178195 (17670) 278571 (24674) 337122 (32144)
Unique reflections 50297 (4908) 52966 (5018) 49991 (4880)
Multiplicity 3.5 (3.6) 5.3 (4.9) 6.7 (6.6)
Completeness (%) 97.47 (94.95) 97.44 (92.67) 97.71 (95.50)
Mean I/(I) 9.25 (2.81) 18.09 (4.21) 15.07 (6.92)
Wilson B factor (Å2) 8.43 7.12 8.81
Rmerge 0.0727 (0.386) 0.0424 (0.273) 0.0803 (0.262)
Rmeas 0.0856 (0.453) 0.0470 (0.306) 0.0876 (0.284)
Rp.i.m. 0.0449 (0.236) 0.0201 (0.136) 0.0344 (0.109)
CC1/2 0.996 (0.884) 0.999 (0.935) 0.992 (0.979)
CC* 0.999 (0.969) 1.00 (0.983) 0.998 (0.995)
Reflections used in refinement 50286 (4906) 52964 (5018) 49982 (4878)
Reflections used for Rfree 2398 (218) 2510 (223) 2400 (222)
Rwork 0.1172 (0.1577) 0.1049 (0.1323) 0.1205 (0.1206)
Rfree 0.1319 (0.1740) 0.1145 (0.1423) 0.1341 (0.1326)
CCwork 0.976 (0.956) 0.977 (0.969) 0.965 (0.977)
CCfree 0.976 (0.945) 0.972 (0.963) 0.941 (0.970)
No. of non-H/D atoms
Total 1502 1467 1474
Macromolecule 1308 1291 1299
Ligands 40 40 40
Solvent 154 136 135
Protein residues 129 130 129
R.m.s.d., bond lengths (Å) 0.011 0.008 0.013
R.m.s.d., angles () 1.46 1.42 1.62
Ramachandran favoured (%) 96.85 97.66 97.64
Ramachandran allowed (%) 3.15 2.34 2.36
Ramachandran outliers (%) 0 0 0
Rotamer outliers (%) 0.7 1.44 0.71
Clashscore 4.18 2.32 4.6
Average B factor (Å2)
Overall 11.06 9.96 11.84
Macromolecule 10.27 9.19 11.33
Ligands 16.50 16.71 16.55
Solvent 16.37 15.25 15.35
filtration, eluting as a single peak around 0.6–0.7 CV, with
fractions F5–F7 being collected for the refolding step
[Figs. 1(a) and 1(b)].
D-HEWLEC was refolded in-column using a low flow rate of
0.1 ml min1, which allowed desalting of the unfolded protein
and separation of the monomeric and oligomeric, misfolded
and partially unfolded fractions [Fig. 1(c)]. The fractions of
refolded D-HEWL in refolding buffer and in deuterated
protein buffer are shown on a 12% SDS–PAGE gel in
Supplementary Fig. S3. The refolding yields were impacted by
the fact that the molecular weight of HEWL is close to the
lower exclusion limit of the gel-filtration column (Mr =
10 kDa), which hindered optimal separation of the monomeric
protein fraction from the denaturing buffer. Injections of
6.5 mg unfolded protein resulted in average refolding yields of
20%. The expression, purification and refolding strategy
yielded 186 mg of pure protein per litre of culture on average,
from which, considering a consistent refolding yield of 20%,
37 mg was recovered in a native-like state. These results
represent more than a threefold increase in D-HEWL
production compared with the P. pastoris system [Fig. 1(d)].
3.2. All non-exchangeable H positions are fully deuterated in
both D-HEWLEC and D-HEWLPP
The deuteration level of D-HEWLEC and D-HEWLPP was
assessed by LC/ESI-MS. Prior to the MS experiments, both
samples were dialyzed against 50 mM sodium acetate pH 4.5
buffer in H2O to avoid partial back-exchange during the
experiment. Therefore, the expected masses included D in all
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Figure 1
The expression of insoluble D-HEWL in E. coli followed by refolding increases the yield of protein production by more than threefold. (a)
Chromatogram from the denaturing SEC, yielding pure unfolded D-HEWLEC, which eluted at 0.6–0.7 CV. (b) Fractions from the denaturing SEC on a
12% SDS–PAGE gel. Lane S, Precision Plus Protein Dual Xtra Standards (Bio-Rad); lane I, injected sample of unpurified D-HEWLEC from the
inclusion-body washing steps; lanes F1–F9, collected fractions from the denaturing SEC as indicated at the top of (a). Fractions F5–F7 were used in
subsequent refolding experiments. (c) Refolding SEC chromatogram, where monomeric D-HEWL elutes at 0.9 CV. The fractions eluting before and
after the monomeric refolded D-HEWLEC are likely to be misfolded or oligomeric and partially unfolded forms of D-HEWLEC, respectively. This is
followed by the elution of the guanidine–HCl and the DTT from the denaturing buffer, as shown by the increase in conductivity. (d) Comparison of the
D-HEWL expression yields between the two systems, E. coli and P. pastoris. *Considering an average refolding yield of 20%, the final yield of
D-HEWLEC production is 37 mg l
1 without further denaturing and refolding of the misfolded, oligomeric and partially unfolded fractions.
Table 2








Expected mass of perdeuterated
variant in H2O (Da)
Observed mass in
H2O (Da)
D-HEWLEC 14362 698 256 15064 15060
D-HEWLPP 14305 696 255 15005 15005
non-exchangeable positions (i.e. bound to C) and, with full
back-exchange, H in all labile positions (Table 2).
D-HEWLEC has 130 residues, with one additional glycine at
the N-terminus compared with the other HEWL variants
studied (Supplementary Fig. S1), resulting in differences in the
expected masses. The masses observed by MS of 15 060 and
15 005 Da (Supplementary Fig. S4) for D-HEWLEC and
D-HEWLPP, respectively, closely match the expected values
(Table 2) and verify the successful replacement of H atoms by
D atoms in non-exchangeable positions. D-HEWLEC shows a
minor difference of 4 Da between the expected and the
observed masses, which shows that 99.4% of all non-
exchangeable positions are occupied by D. The D-HEWLPP
observed mass exactly matched the expected value of the fully
deuterated form.
3.3. Perdeuterated variants of lysozyme are stable and active
DSF assays were performed to retrieve information on the
folding and stability of D-HEWLEC and D-HEWLPP using
H-HEWL as a reference. Results were obtained using the
same deuterated buffer (50 mM sodium acetate pD 4.5 in
D2O) and showed that both variants of D-HEWL are ther-
mally less stable than H-HEWL [Figs. 2(a) and 2(b)]. The
refolded D-HEWLEC is less thermally stable than D-HEWLPP,
with a difference in melting temperature of 4.9C. Moreover,
compared with H-HEWL, the refolded D-HEWLEC shows a
decrease in thermal stability of 6.8C. If the D-HEWLEC was
not completely separated from denaturing salts upon
refolding, a small population of misfolded protein could
potentially be present in the sample. To test this, D-HEWLEC
crystals were washed and dissolved in protein buffer (from
now on referred to as D-HEWLEC after crystallization) and
analyzed by DSF [Figs. 2(a) and 2(b)]. With differences of less
than 1C observed between D-HEWLEC before and after
crystallization, it was concluded that the lower thermal
stability was not attributable to the presence of misfolded
protein in the D-HEWLEC sample.
The enzymatic activities of the D-HEWL variants were also
assessed. As part of this, DSF measurements were performed
in activity-assay buffer (0.1 M sodium phosphate buffer pH 7.5
in H2O with 0.1 M NaCl and 2 mM NaN3). A systematic
decrease in stability of all of the samples was observed in this
buffer [Fig. 2(a)]. The D-HEWL variants are less active than
H-HEWL (D-HEWLEC and D-HEWLPP exhibited 51% and
67% of the activity of H-HEWL, respectively; both were
significantly different, with t-test p values of <0.05) [Fig. 2(c)].
Conversely, the activity difference between D-HEWLEC and
D-HEWLPP is not significant (p = 0.19). As for the thermal
stability, no significant differences were observed between
D-HEWLEC before and after crystallization.
3.4. Structural similarities and differences
Atomic resolution X-ray diffraction data were collected for
all three variants: H-HEWL, D-HEWLEC and D-HEWLPP.
The data sets all extended to at least 1.00 Å resolution,
although, as evident from the merging statistics (Table 1), the
resolution cutoff was limited by the experimental geometry
(detector distance and coverage) and not by the diffraction
power of the crystals. Given the low symmetry of the P1 space
group, a data-collection strategy with sweeps collected in two
distinct crystal orientations (different  angles) was imple-
mented. An overall completeness of greater than 90% was
obtained to a resolution of 1.00 Å. Refinement of the three
variants of lysozyme provided the basis for comparison of the
features and differences between the structures. The quality
and resolution of the diffraction data allowed the visualization
of elusive structural detail, including side-chain and main-
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Figure 2
Stability and activity of the HEWL variants. (a) Tm values for H-HEWL,
D-HEWLEC (before and after crystallization) and D-HEWLPP in
deuterated protein buffer (50 mM sodium acetate pD 4.5) and in
hydrogenated activity-assay buffer (0.1 M sodium phosphate pH 7.5,
0.1 M sodium chloride, 2 mM sodium azide). (b) Thermal unfolding
curves (first derivative against temperature) of H-HEWL (green),
D-HEWLEC before crystallization (continuous dark blue line) and after
crystallization (dashed light blue line) and D-HEWLPP (red) in
deuterated protein buffer. (c) Enzymatic activity of H-HEWL (green),
D-HEWLEC (dark blue, before crystallization; light blue, after crystal-
lization) and D-HEWLPP (red) in the hydrogenated activity-assay buffer.
The p-values represent the significance of the homoscedastic hypothesis,
meaning the probability of the pairs of measured values being equal.
chain disorder, and the interpretation of complex hydrogen-
bonding patterns and their underlying structural dynamics.
3.4.1. Secondary and tertiary structures are retained.
Numerous structures of HEWL are available in the PDB,
representing a multitude of crystallization conditions,
different space groups, ligands, humidity levels, mutations etc.,
but a benchmark in this large pool of structures is the P1
structure refined to 0.65 Å reesolution by Wang et al. (2007)
(PDB entry 2vb1). With a r.m.s.d. of 0.23 Å between the C
atoms, the three-dimensional structure of H-HEWL obtained
in our study closely matches this model. There are some
differences between the disorder modelled in the two struc-
tures, which may reflect the difference in resolution of the
corresponding data sets.
In order to perform a comparison of the structure of
H-HEWL with the structures of the two D-HEWL variants,
the model of H-HEWL was obtained from similar crystal-
lization conditions, data-collection and refinement parameters
and resolution limits to those for the D-HEWL structures.
The structural alignment based on C atoms between the
three HEWL variants showed a high degree of similarity, with
an r.m.s.d. of 0.11 Å for both D-HEWLEC and D-HEWLPP in
comparison with H-HEWL [Fig. 3(a)]. The conserved tertiary
and secondary structures indicate that perdeuteration did not
have a significant impact on the overall protein fold, as has
been demonstrated in many neutron crystallographic studies
of other proteins (Artero et al., 2005; Haupt et al., 2014;
Langan et al., 2014; Cuypers, Mason et al., 2013; Yee et al.,
2019; Liu et al., 2007; Koruza et al., 2019). The r.m.s.d. between
the two D-HEWL variants was 0.13 Å, suggesting that the
refolding process had little effect on the global protein fold.
3.4.2. Alternate conformations and hydrogen-bond
patterns. The atomic resolution X-ray data enabled a
detailed description of backbone and side-chain disorder.
Alternate conformations were modelled for approximately
30% of the protein residues. Overall, the structures exhibited
similar disorder patterns; the only exceptions were residues
Glu7, Asn19, Ser24, Gln41, Thr89 and Gln121 (Supplemen-
tary Fig. S5). Given the high resolution of the X-ray data, the
structural analysis includes a comparison of hydrogen bonds in
the three structures, as this is of central interest for an
understanding of differences in thermal stability.
Even at this high resolution, the electron-density maps in
specific regions do not allow unambiguous modelling. Thus,
the results from HBPLUS (McDonald & Thornton, 1994)
were filtered considering the RSCC and RSZO metrics from
EDSTATS (Tickle, 2012; details are shown in Supplementary
Figs. S6–S8) to ensure the reliability of the subsequent
analysis. The following residues did not comply with the
applied cutoffs in one or more of the structures: Gly0, Ala9,
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Figure 3
The overall structures and normalized B factors of the three HEWL variants. (a) Ribbon representation of the structurally aligned models of H-HEWL
(green), D-HEWLEC (blue) and D-HEWLPP (red). (b) The active site and the polysaccharide-binding cleft shown for all three molecules: H-HEWL
(green), D-HEWLEC (blue) and D-HEWLPP (red). (c) Plot of the normalized residue-averaged B factors from the H-HEWL (green), D-HEWLEC (blue)
and D-HEWLPP (red) models.
Gly26, Asn27, Ala32, Phe38, Tyr53, Leu56, Ile58, Trp62,
Cys64, Thr89, Ser91, Val92, Asp101, Gly102, Asn103, Gly104,
Met105, Asn106, Ala107, Cys127 and Leu129. Discrepancies
in hydrogen-bond lengths larger than 0.1 Å between all three
structures were considered and inspected individually.
A comparison of the active site, with the catalytic residues
Asp35 and Glu52, and the polysaccharide-binding cleft
(Phillips, 1967) initially showed only minor differences in
residue positions and conformations [Fig. 3(b)]. However, the
residues Lys97–Gly104 display a high level of disorder,
reflected by increased B values, most noticeably in the struc-
ture of D-HEWLEC [Fig. 3(c)]. As also reported by Wang et al.
(2007), this region contains main-chain disorder due to a
partial peptide-plane flip of Asn103, which causes strain on the
backbone of residues Lys97–Gly104 (Fig. 4), propagating
through hydrogen-bond interactions. The occupancy of the
loop conformation associated with the flipped Asn103
(conformation B) was 46% in D-HEWLEC, 38% in
D-HEWLPP and 33% in H-HEWL. Structural alignment of
this region (Lys97–Gly104, using all atoms) showed that in
comparison with H-HEWL, D-HEWLEC and D-HEWLPP
deviate by 0.27 and 0.16 Å, respectively. Meanwhile, the
r.m.s.d. between D-HEWLEC and D-HEWLPP was 0.21 Å.
Main-chain disorder was also observed in the Lys13–Gly16
region, which is part of the first -helix, with variations in the
Gly16 N–Lys13 O hydrogen bond (Supplementary Fig. S9).
However, this relates to the disorder of the His15 side chain,
together with the interaction of Lys13 with the C-terminal
residue Leu129 and of Gly16 with the disordered Arg114 via
crystal contacts. The alternate conformations of His15, A and
B, appear to be stabilized by water-mediated hydrogen bonds
to Asn93 and by a hydrogen-bond to nitrate ion 9, respectively
(Fig. 5).
The most evident differences between the structures in this
region are the disorder of Thr89 in H-HEWL, and more
profoundly in D-HEWLPP, and the absence of water 81 in
D-HEWLPP. For His15A, water 81 seems to be important in
restraining Thr89 in H-HEWL and D-HEWLEC, contrary to
the observation in D-HEWLPP. In the absence of water 81 in
D-HEWLPP, a significant displacement of Thr89 occurs,
stabilizing the His15 side chain. Furthermore, a steric clash
with Thr89 appears to force flipping of the Asp87 side chain.
The visualization of this extended hydrogen-bond network is
supported by the similar refined occupancies of His15A, water
57, Thr89B and Asp87B of 47%, 34%, 39% and 41%,
respectively. Meanwhile, in the H-HEWL and D-HEWLEC
structures, His15A interacts with Asn93 and Asp87 through
hydrogen bonds mediated by waters 57 and 81, as shown by
their refined occupancies (51% for His15A, 65% for water 57
and 55% for water 81 in H-HEWL; 58% for His15A, 70% for
water 57 and 55% for water 81 in D-HEWLEC).
On the other hand, His15B in all three HEWL structures
forms a hydrogen bond to nitrate ion 9, which is further
stabilized by hydrogen bonds to Ile88 N and water 72. This
interaction network is supported by the refined occupancies of
His15B and nitrate ion 9 (42% and 49% in H-HEWL, 49%
and 56% in D-HEWLEC and 66% and 47% in D-HEWLPP,
respectively). The low B factor refined for the O2 atom of this
nitrate ion revealed the presence of a water molecule when the
nitrate is not occupying the space (the occupancy of nitrate 9
O2 is 1, while the nitrate occupancy is refined based on N, O1
and O3). Additionally, in D-HEWLPP the His15B side chain
forms a hydrogen bond to the nitrate ion, which replaces its
interaction with Thr89 and promotes the interaction of
Thr89A with Asp87A, as shown by their matching occupancies
of 61% and 59%, respectively.
The presence of Gly0 at the N-terminus of D-HEWLEC
influences the hydrogen-bond pattern in this region. Specifi-
cally, Gly0 cancels the Lys1 N–Thr40 OG1 interaction, instead
favouring a Thr40 OG1–Lys1 O hydrogen bond (Fig. 6).
Additionally, Gly0 does not interact with other protein resi-
dues and increases the disorder of the N-terminus of
D-HEWLEC. In H-HEWL and D-HEWLPP, water molecule
138 occupies the position of Gly0 and enables water-mediated
hydrogen bonds between Lys1 N and Ser86B OG.
In addition, several minor differences between the three
structures were noted, where D-HEWLEC in particular stands
out. In D-HEWLEC Asn19 was observed in a single confor-
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Figure 4
Increased disorder in the Lys97–Gly104 region of D-HEWLEC compared with both D-HEWLPP and H-HEWL. Representation of the backbone disorder
resulting from the strain induced by the Asn103 partial peptide flip in D-HEWLEC (a), D-HEWLPP (b) and H-HEWL (c). The 2Fo Fc electron-density
maps represented are contoured at 1.
mation, allowing a stable Gly22 N–Asn19 O hydrogen bond of
2.96 Å, while in D-HEWLPP and H-HEWL disorder was
observed, with the major conformation (occupancies of 60%
and 69%, respectively) resulting in a significantly longer
Gly22 N–Asn19 O hydrogen bond (Supplementary Fig. S10).
This variation is correlated with the alternate conformations
of the Asn19 side chain in H-HEWL and D-HEWLPP, where
the minor conformation of Asn19 participates in crystal
contacts with Ser81 O, while the major conformation is
involved in crystal contacts with the disordered Gln41 OE1. In
D-HEWLEC only the latter conformation is present, as Gln41
is ordered, resulting in a single conformation of Asn19 with
the shorter intramolecular Gly22 N–Asn19 O hydrogen bond.
This shorter interaction suggests a more stable 310-helix
between Tyr20 and Gly22 in D-HEWLEC, although this may
be a consequence of the stable crystal contact between the
side chains of Asn19 and Gln41, thus not influencing stability
in solution.
In all three structures Ser81 adopts two distinct conforma-
tions, giving rise to different Leu84 N–Ser81 O hydrogen-
bond lengths (Supplementary Fig. S11), where the major
conformation corresponds to the shorter of the two inter-
actions. However, the lower occupancy of this major confor-
mation in D-HEWLEC (66% compared with 82% in both
D-HEWLPP and H-HEWL), together with the larger differ-
ence in the hydrogen-bond lengths of the two conformations,
indicates that the Leu84 N–Ser81 O interaction is potentially
weaker in D-HEWLEC, destabilizing its 310-helix.
Furthermore, in another 310-helix (Val120–Arg125), minor
variations were observed in the Arg125 NH2–Asp119 OD2
and Arg125 NH2–Gln121B OE1 hydrogen bonds, with the
shorter Arg125 NH2–Asp119 OD2 interactions found in H-
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Figure 5
Disorder and hydrogen-bond patterns surrounding the His15 side chain. A representation is shown of the overall environment around His15 in
D-HEWLEC (a), D-HEWLPP (b) and H-HEWL (c). The 2Fo  Fc electron-density maps represented are contoured at 1. Highlighted hydrogen-bond
interactions correlated with His15 side-chain disorder are shown for conformation A of D-HEWLEC (d), D-HEWLPP (e) and H-HEWL ( f ) and for
conformation B of D-HEWLEC (g), D-HEWLPP (h) and H-HEWL (i).
HEWL (Supplementary Fig. S12). Additionally, in D-
HEWLEC Arg5 forms longer side chain–main chain hydrogen
bonds to Trp123 O and Arg125 O, respectively, representing a
minor destabilization of the tertiary structure in comparison to
D-HEWLPP and H-HEWL.
4. Discussion
By using an E. coli expression system in parallel with in-
column protein refolding, it is possible to obtain a more than
threefold gain in the production of D-HEWL in comparison
with yields for the P. pastoris system. The increase in yield is
proportional to the financial cost reduction of protein
production, since the approximate cost per litre of E. coli and
P. pastoris cultures is similar. The cost is dominated by the
deuterated materials, which for D-HEWL production using
the E. coli system is roughly 140 euros per milligram of
protein, in comparison to approximately 450 euros per milli-
gram using P. pastoris. Although non-optimal in separating
monomeric lysozyme from denaturing salts, the SEC column
used in refolding provided the highest yields when compared
with analytical columns. This observation is related to diffi-
culties in removing such high concentrations of salt and the
need to separate oligomeric from monomeric fractions while
injecting milligram amounts of sample. Furthermore, the yield
of the protocol can be further increased by dialyzing the
oligomeric, misfolded and partially unfolded fractions of
D-HEWLEC from refolding against denaturing buffer and
reinjecting them into a refolding SEC. Complete perdeutera-
tion of non-exchangeable sites in both D-HEWL variants was
demonstrated by mass spectrometry. A similar refolding
approach has been applied for the production of a perdeut-
erated antifreeze protein (Petit-Haertlein et al., 2009), with the
difference that refolding was carried out in a deuterated
buffer. The refolding of perdeuterated lysozyme reported here
is, to our knowledge, the first example of a perdeuterated
protein exceeding 7 kDa and with multiple disulfide bonds.
Refolding in D2O was also attempted; however, it led to a
decrease in the refolding yield (data not shown) owing to
reduced separation of the monomeric protein fraction and
denaturing salts. This observation is likely to be due to the
slower dynamics in heavy water, resulting in a delay in the
elution of the folded monomeric lysozyme fraction. Addi-
tionally, using D2O would not be cost-effective, given the
numerous refolding SEC runs that are required to obtain
several milligrams of refolded protein. As the refolding of
D-HEWLEC was performed in H2O buffer, it may result in the
caging of H atoms in exchangeable positions, i.e. exchanged
during the unfolded state and then trapped upon refolding.
The protein fold may keep specific regions protected from any
interaction with solvent molecules; hence, to exchange these H
atoms to D atoms the protein must be at least partially
unfolded in D2O buffer. To unambiguously identify the posi-
tions occupied by caged H atoms in the protein structure,
neutron crystallography or NMR experiments are required.
An indication of relevant positions is found in a reverse setup,
where 20 H atoms were exchanged to D using unfolding and
refolding processes of H-HEWL in D2O (Kita & Morimoto,
2016), as observed in the neutron structure deposited in the
PDB (PDB entry 6k8g; Kita & Morimoto, 2020).
Biophysical characterization of both D-HEWL variants and
commercially available unlabelled HEWL shows that both
D-HEWL molecules are stable and active. The perdeuterated
variants showed lower thermal stability relative to the
hydrogenated protein both in D2O and H2O buffers, in line
with what has been reported in several biophysical studies on
protein deuteration (Berns, 1963; Hattori et al., 1965; Brock-
well et al., 2001; Meilleur et al., 2004; Koruza et al., 2018;
Nichols et al., 2020). Additionally, it seems that both hydro-
genated and perdeuterated forms of HEWL have an increased
transition temperature in D2O compared with H2O, as
described in previous studies (Makhatadze et al., 1995;
Efimova et al., 2007). However, the data presented here are
not sufficient to draw definitive conclusions on this solvent-
isotope effect, since the D2O and H2O buffers used have
significantly different compositions (aimed at crystallization
and activity measurements, respectively). Additionally, the
presence of residual H atoms in H-HEWL, due to the limited
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Figure 6
Representation of the differences in the hydrogen-bond patterns involving Lys1 and Thr40 in D-HEWLEC with the additional Gly0 residue (a),
D-HEWLPP (b) and H-HEWL (c). The 2Fo  Fc electron-density maps represented are contoured at 1.
time for H/D exchange and the limited solvent accessibility of
specific protein regions to the D2O solvent, cannot be ruled
out. The differences in protein thermal stability can be
correlated with the enzymatic activities. Perdeuteration of the
protein was expected to affect its dynamics and consequently
its stability and activity, and in this study a decrease in stability
as well as in relative activity compared with H-HEWL is
observed. The differences between D-HEWLEC and
D-HEWLPP are likely to be a consequence of the refolding
procedure. The additional N-terminal glycine residue in
D-HEWLEC may also cause a slight destabilization of the
protein. However, the activity results do not allow a conclusive
correlation of the effect of refolding on activity, since under
the conditions used the difference in activity between the two
perdeuterated variants is not statistically significant. This
further emphasizes the similarity between the D-HEWL
variants and validates the refolding approach to obtain stable
and active D-HEWL.
While a large number of HEWL crystal structures have
been published, the detailed comparisons needed for this
study of perdeuterated and hydrogenated HEWL required the
growth of crystals under closely comparable conditions, with
only minor variations relating to the seeding procedure and
precipitant concentrations. The atomic resolution X-ray data
for both perdeuterated samples, as well as for the reference
unlabelled sample, have been analyzed in detail, revealing
structural features that can be related to the observations on
stability and activity. The crystal packing and overall struc-
tures were, as expected, found to be essentially identical, with
negligible differences in the unit-cell parameters. Moreover,
the nitrate and acetate ions that are essential to crystallization
were located and refined in identical positions in the three
models, with similar B factors (Table 1). However, despite the
close similarity between the three structures, there are some
clear variations in hydrogen-bond distances, which appear to
be related to the differences in protein stability.
An important factor contributing to the reduced thermal
stability of the D-HEWL structures is the effect of H/D
substitution on hydrophobic interactions. As described by
Hattori et al. (1965), deuterium-substituted nonpolar amino-
acid side chains have a reduced steric requirement due to the
smaller amplitudes of vibration of the C—D bond compared
with C—H, leading to weaker hydrophobic interactions
between the residue side chains; this has also been noted in
mass-spectrometric studies (Yee et al., 2016). Additionally,
D2O has a stronger hydrophobic effect than H2O, leading to
changes in solvation, more compact structures and a decrease
in protein flexibility (Svergun et al., 1998; Sasisanker et al.,
2004; Efimova et al., 2007; Jasnin et al., 2008). This is observed
in the crystal structures, where a larger number of structural
water molecules were identified in H-HEWL compared with
both D-HEWL variants. Moreover, the molecular surface and
solvent-accessible surface areas of D-HEWLPP were 15 555
and 8 200 Å2, respectively, whereas those for H-HEWL
were 15 725 and 8 274 Å2. The corresponding values for
D-HEWLEC are not directly comparable due to the presence
of the additional Gly0 residue. Finally, protein dynamics are
expected to be influenced by deuteration since D is twice as
heavy as H, which in the case of HEWL corresponds to a mass
increase of at least 700 Da. All of these factors play a role in
the interaction with substrate molecules, since the enzymatic
activity is strongly dependent on protein dynamics and the
displacement of water molecules to accommodate the
substrate, consistent with the decreased activity observed in
the perdeuterated variants.
The disorder observed in the structures is evidently linked
to the intricate networks of hydrogen bonds. However, only a
few regions of the models show distinct disorder due to
variations in the hydrogen-bond patterns. These are the cases
of the Thr40 N–Lys1 O and Gly22 N–Asn19 O hydrogen
bonds and the His15 side chain. The differences observed in
the Thr40 N–Lys1 O interaction are due to the presence of
Gly0 at the N-terminus of D-HEWLEC, leading to increased
disorder. In the case of the Gly22 N–Asn19 O hydrogen bond,
the alternate conformation of Asn19 is favoured by the side-
chain disorder of Gln41 that is present in D-HEWLPP and
H-HEWL, resulting in a weaker Gly22 N–Asn19 O inter-
action. Finally, the His15 side-chain disorder, with differ-
entiation between the two conformational networks A and B,
appears to be linked to partial occupancies of waters 57 and 81
and of nitrate ion 9, and potentially to variations in protona-
tion states. In D-HEWLPP, the absence of water 81 seems to
promote the disorder of Thr89 and subsequently the flipping
of Asp87 to stabilize His15A. The protonation states are not
evident, even in the 0.65 Å resolution structure (Wang et al.,
2007), and obtaining an unambiguous picture of the proton-
ation of lysozyme will require high-quality and high-resolution
neutron diffraction data. In conclusion, these minor variations
in the protein structure alone are not likely to explain the
decrease in stability observed in the D-HEWL structures.
The main difference in the crystal structures that can be
correlated with variations in protein stability is the disorder of
the Lys97–Gly104 region due to the partial peptide-plane flip
of Asn103. Peptide-plane flipping occurs in the early stages of
protein folding, particularly when glycine is in the i + 1 posi-
tion, since the structure is not yet restrained by hydrogen
bonds between protein residues (Hayward, 2001). Although
not frequent due to its energetically unfavored conformation,
peptide flipping remains underrepresented in the PDB
(Berman et al., 2000). This was found to be correlated, among
other factors, with the resolution of the X-ray data available to
determine the crystal structures (Stewart et al., 1990; Weiss et
al., 1998). Peptide flipping can be responsible for amyloid
formation (Milner-White et al., 2006; Yang et al., 2006) or can
confer structural flexibility that is essential for protein func-
tion (Weiss et al., 1998; Ludwig et al., 1997; Keedy et al., 2015).
As described by Wang et al. (2007), the backbone disorder in
this region is a consequence of the Asn103 peptide-plane flip.
In their H-HEWL crystal structure determined from X-ray
data at 0.65 Å resolution, the flipped conformation has a
refined occupancy of 35%, which is consistent with our
H-HEWL model in which the flipped conformation of Asn103
was refined with an occupancy of 33%. This observation
suggests that the likelihood of Asn103 peptide flipping in
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native H-HEWL is constant. Conversely, in the D-HEWL
models the refined occupancies for the flipped conformation
are greater: 46% in D-HEWLEC and 38% in D-HEWLPP.
While D-HEWLEC was chemically unfolded and then refolded
by slowly changing its buffer from 6 M guanidine–HCl to a
2 M urea H2O solution, D-HEWLPP was folded in deuterated
conditions during expression. Thus, both D-HEWL variants
were subjected to different folding environments compared
with H-HEWL, which are associated with slower solvent
dynamics and the H/D-isotope effect, which could favour the
peptide-plane flip of Asn103. Interestingly, when the protein is
completely unfolded, as is the case for D-HEWLEC, it appears
that the probability of the peptide flip occurring or not is
identical, suggesting a high degree of freedom between the
two conformations. In the case of D-HEWLPP, the solvent-
isotope effect may be responsible for this by slowing down the
folding dynamics and increasing the likelihood of peptide
flipping. This destabilized region is not only part of the enzyme
active site, and therefore relevant to substrate binding, as
reported by Strynadka & James (1991), but also protects a
hydrophobic pocket containing Trp28, Trp62, Trp63 and
Trp108. The increase in disorder of this loop region may
therefore be correlated with the decrease in protein thermal
stability measured for D-HEWLEC when compared with
D-HEWLPP.
The results presented here support the widespread under-
standing that perdeuteration has no significant effect on
secondary and tertiary protein structures. Nevertheless, the
hydrophobic effect and the slower dynamics caused by
perdeuteration have an impact on protein stability and
activity. Ultimately, this study emphasizes the capability to use
E. coli for the expression of recombinant insoluble protein and
subsequent refolding for the production of large amounts of
perdeuterated material, enabling a wide range of new science
in the future. In addition, this work highlights the fact that
studies of deuterated proteins can reveal crucial and highly
specific aspects of protein conformation related to variations
in protein thermal stability.
5. Data accessibility
The X-ray diffraction data and models have been deposited in
the PDB with accession codes 7ave (D-HEWLEC), 7avf
(H-HEWL) and 7avg (D-HEWLPP).
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